SCHEMBL20054315

SCHEMBL20054315

C=C1CCC(C(=C)N)CC1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.35
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11880935 0.76
SCHEMBL8962209 0.74 LMNA (0.48) ESR2LMNA
SCHEMBL10079143 0.71
SCHEMBL20204130 0.71
SCHEMBL15319201 0.70 ALOX15 (0.33) ESR2
SCHEMBL4636245 0.69
SCHEMBL39569 0.68 GABRP (0.44) ESR2LMNA
SCHEMBL24062098 0.67 ESR2 (0.31) ESR2
SCHEMBL14647427 0.66 LMNA (0.41) LMNA
SCHEMBL13113422 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed